Implementing and scaling up programmes to remove human rights-related barriers to HIV services

On April Frontline AIDS presented a Practical guidance to programming aimed at removing human rights-barriers to HIV services. This guide has been developed to support implementers to plan, roll out and scale up effective, evidence-informed programmes to remove human rights-related barriers to HIV services.

Launch of open consultation on Global Fund Strategy development

Global Fund has launched an open consultation on the development of the post-2022 strategy. A background presentation is attached that explains the consultation process and lists a set of questions for reflection and input. The first round of input received by 1 September 2020 will be reviewed by the Global Fund Board’s Strategy Committee in […]

Get Engaged in the ‘UNAIDS Strategy Beyond 2021’ Development Process

UNAIDS is now in the process of developing its next Strategy for 2021 and beyond. The timeline for developing the Strategy was supposed to have started early this year, but it was hampered by the COVID-19 pandemic. It has now been extended to accommodate a longer consultation period to ensure a full and more meaningful […]

Global Fund COVID-19 Response Mechanism (C19RM). Questions & Answers

C19RM is a mechanism that the Global Fund has put in place for countries to access funds to fight COVID-19, mitigate the impact that the new pandemic is having on programs to fight AIDS, TB and malaria, and prevent fragile health and community systems from being overwhelmed.

Roundtable organized by Global Fund

On 26 May (Russian) and 27 May (English) at 10.00 am (Geneva time) Developing Country NGO delegation of the Global Fund Board and the Global Fund Secretariat are organizing the Roundtable “Responses to HIV and TB in times of COVID-19 – strengthening engagement with civil society and communities in Eastern Europe and Central Asia (EECA)”

Global Fund funding opportunity – COVID-19 Response Mechanism

The COVID-19 Response Mechanism (C19RM), approved in April 2020, authorizes US$500 million in funding in addition to grant flexibilities. C19RM can be used across the three diseases and the health system, even if a country only has a single Global Fund grant for one component. The CCM will assess the most urgent needs and direct […]